| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Matthew P Miller last filed a Form 4 in March 2023, as Chief Operating Officer at TOI. Matthew P Miller's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Matthew P Miller has 5 Form 4 filings on record from March 2022 to March 2023, all as Chief Operating Officer at Oncology Institute (TOI), 2022–2023.
The 10 reported transactions were 4 stock awards, 4 option or other derivative awards, 1 open-market purchase and 1 disposition back to the company.
Counted by filing, the open-market trades come to 1 purchase worth about $70K and no sales.
The only open-market purchase was 73,684 shares of TOI at an average $0.95 on December 16, 2022, about $70K. Twelve months later TOI was up 53%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | TOI Oncology Institute, Inc. | Chief Operating Officer | Buy | 73,684 | $0.95 | $69,999.80 | +72.5% | -34.1% | +53.4% |